UCI-led study reveals how SARS virus hijacks host cells
Findings could prove beneficial in the development of therapies
Irvine, Calif., Aug. 22, 2013 — UC Irvine infectious disease researchers have uncovered components of the SARS coronavirus – which triggered a major outbreak of severe acute respiratory syndrome in 2002-03 – that allow it to take over host cells in order to replicate.
This insight is critical for a full understanding of any outbreaks caused by such viruses and may prove beneficial in the development of therapies not only for human coronavirus infections but for other pathogenic illnesses as well. Study results appear online in the July/August issue of mBio.
Megan Angelini, a graduate student in Professor Michael Buchmeier’s laboratory in the Department of Molecular Biology & Biochemistry at UC Irvine, and colleagues found that three proteins in the SARS coronavirus – nsp3, nsp4 and nsp6 – have the ability to hijack a host cell’s internal membranes and utilize them to make more virus.
“Understanding how the virus uses the host cell to reproduce itself could lead to potential therapies for these kinds of pathogens,” said Buchmeier, who is also deputy director of the Pacific Southwest Regional Center of Excellence for Biodefense & Emerging Infectious Diseases at UC Irvine.
Additionally, he said, since membrane rearrangement is a tactic employed by all known positive-sense, single-stranded RNA viruses, including those responsible for polio and dengue fever, this work adds to that body of knowledge.
Although the majority of infections caused by coronaviruses in humans are relatively mild, the SARS outbreak of 2002 and 2003 and the emergence last fall of the Middle East respiratory syndrome coronavirus highlight their ability to potentially infect millions around the globe.
Benjamin Neuman of England’s University of Reading and Marzieh Akhlaghpour ’11 also contributed to the study, which was supported by the National Institutes of Health (grants 5T32AI007319-23 and AI059799) and the California Center for Antiviral Drug Discovery (MRPI grant 143226).
The study can be accessed here: http://mbio.asm.org/content/4/4/e00524-13
If you are interested in learning more about how to support research by faculty at Bio Sci, please contact Andrew DiNuzzo at firstname.lastname@example.org.
About the University of California, Irvine: Located in coastal Orange County, near a thriving employment hub in one of the nation’s safest cities, UC Irvine was founded in 1965. One of only 62 members of the Association of American Universities, it’s ranked first among U.S. universities under 50 years old by the London-based Times Higher Education. The campus has produced three Nobel laureates and is known for its academic achievement, premier research, innovation and anteater mascot. Led by Chancellor Michael Drake since 2005, UC Irvine has more than 28,000 students and offers 192 degree programs. It’s Orange County’s second-largest employer, contributing $4.3 billion annually to the local economy.
Media access: Radio programs/stations may, for a fee, use an on-campus ISDN line to interview UC Irvine faculty and experts, subject to availability and university approval. For more UC Irvine news, visit news.uci.edu. Additional resources for journalists may be found at communications.uci.edu/for-journalists.